A practical guide to the diagnosis and treatment of leprosy in the basic health unit
Wheate HW, Pearson JM. 4th ed. Würzburg: GLRA; 1990.
Management of leprosy.
Wheate HW. British medical bulletin. 1988; 44(3):791-800.
Operational problems in leprosy programmes when the endemicity declines.
Wheate HW, Harris GF. Leprosy review. 1987; 58(1):1-5.
Six months MDT for paucibacillary leprosy: nerve damage and relapse.
Wheate HW. Leprosy review. 1986; 57(2):179.
Report of the sub-group on rehabilitation
Browne SG, Wheate HW, Bourrel P. Quaderni di Cooperazione Sanitaria. 1983; NO. 1195 - 196.
The organization and management of chemotherapy in the field.
Wheate HW. Leprosy review. 1983; 54(3):161-2.
Reversal reaction: the prevention of permanent nerve damage. Comparison of short and long-term steroid treatment.
Naafs B, Pearson JM, Wheate HW. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1979; 47(1):7-12.
Dapsone resistance in patients with treated lepromatous leprosy.
Wheate HW. Leprosy review. 1979; 50(3):252-3.
The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients.
Naafs B, Wheate HW. Leprosy review. 1978; 49(2):153-7.
Correspondence: effect of clofazimine on the urinary excretion of DDS (dapsone).
Grabosz JA, Wheate HW. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1975; 43(1):61-2.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.